UltraSight raised $24 million to expand its cardiac ultrasound platform across U.S. health systems and develop acute-care workflows.
- Amount
- $24M
- Stage
- Series B
- Announced
- 23 September 2026
- Lead
- Alive HealthTech Growth Fund
- Other investors
- Deep Insight, Star51 Capital, Connecticut Innovations, eHealth Ventures, Mayo Clinic Ventures, NYU, Iron Nation
- Use of funds
- Fund U.S. commercial expansion of the UltraSight Echosystem and accelerate acute cardiac workflow engineering for ICU and mechanical circulatory support settings.
- Checked
- Amount and date checked against the press source